stories are uneven-in some situations, fantastic care is provided and in others little or no discussion with professionals was available before, during or after treatment regarding hormone health, fertility options or issues concerning sexuality. These narratives create the story of an ongoing gap in the discipline where centers of true excellence, largely part of the Oncofertility Consortium National Physicians Cooperative (Bortoletto, Confino, Smith, Woodruff, & Pavone, 2017; Duncan et al., 2015; Oncofertility Consortium, n.d.) exist at our great academic medical centers, while the vast majority of hospitals lack linked services.
Here I explore the major themes of these contributed pieces as well as some of the contrasting experiences. I close with the insights presented by the narrative and the way these stories inform contemporary debates in the field. To be sure, these stories are filled with the raw emotion of having "cancer" as part of a life story and when coupled with lost fertility, the wounds are even more gapping. Reading these stories provides equal measures of empathy and determination to continue the work. I firmly believe that the promise of basic science in medicine is that tomorrow's patient will be treated better than today's. These narratives reveal the need to keep working.
Theme 1: Financial Toxicity
Comments regarding the cost of fertility interventions were found in nearly every narrative. Financial toxicity is a term used to describe the impact financial issues have on patient outcomes (de Souza et al., 2017; Zafar, 2016) . This issue is particularly problematic for the oncofertility cohort-many have not reached their economic peak and a cancer diagnosis can derail or halt education or career building opportunities that in addition to the extraordinary costs for cancer and fertility management can topple many survivors. Some of the comments include: " . . . still in debt from the treatment, it was all too much." [Alexandria Yi] "My insurance company refused to cover any of these costs because it did not consider the potential of infertility a medical necessity as I was not infertile yet. I had thousands of dollars of law school loans and shortly, I would endure tremendous unforeseen medical expenses, so I did not know where I would find the money to cover the fertility procedure." [Rijon Charne] "There is a yearly fee for storage of the healthy sperm sample, and insurance does not pay for this. At the time, insurance also didn't pay for the doctor visit or sperm analysis. The out of pocket costs for this-on top of all the cancer bills-is quite overwhelming for anyone. I count myself lucky and grateful that my parents helped me defray the costs." [Bryan Ettinger] " Money is the most uncomfortable and challenging aspect of our story. . . . This is an unconscionable amount of money for anyone to spend let alone young people facing other costs due to cancer." [Erin McKinney & Robert Curran] 
Theme 2: Resentment and Regret
Each narrative reflected on the way the individual managed the emotions of the oncofertility diagnosis. Most of the emotions are raw and negative with few folks finding peace with the process or the outcome. A survey of younger adult female cancer survivors who were not advised about the fertility loss associated with cancer treatment found them to register at the post-traumatic stress disorder level (Canada & Schover, 2012) . This is a sobering finding and these narratives reinforce how essential family building options are as a basal human emotion. "I resent not being able to make an informed decision about a future pregnancy . . ." [Grazia De Michele] "Cancer unfairly took the choice away from me after I was diagnosed . As an aside, there was one account of adoption.
"More than anything, I'm lucky that I don't have to navigate the intricacies of today's dating world as an infertile, menopausal, 27-year-old who is missing a kidney. I'm lucky that my extremely supportive boyfriend happens to be adopted and is open to building a family in one of the many other ways there are to do so." [Maggie Rogers] Non-biological family building is something that needs more attention in this population, enabling parenting in a way that can be very satisfying. That said, ensuring that potential adoptive mothers with a cancer diagnosis have the opportunity to adopt remains an impediment despite the work of the Oncofertility Consortium on this topic (Gardino, Russell, & Woodruff, 2010; Quinn, Zebrack, Sehovic, Bowman, & Vadaparampil, 2015) . As with other biologically based fertility interventions, non-biological family options need to be presented to families to mitigate or even eliminate the regret that is so evident in these narratives.
Surprisingly absent from the narratives, for me, were mentions of community-knowing other young cancer patients with similar concerns; comments about bringing awareness to the issue of cancer at a young age; and, discussion of the research environment surrounding care. The Oncofertility Consortium hosts patient advocates each year at our annual meeting and my calibration is from these individuals who may see the world through a prism that has been chiseled differently initially or been re-honed by their activism. I'm not sure which informs the other but I think it is important for the treating community to know that despite our best efforts, many individuals continue to self-navigate, encounter doctors that are insensitive to their needs, and are not aware of the most recent options for males and females and who are simply trying to make every day count.
Perhaps the most important insight from these narratives is the depth of human emotion associated with the loss of fertility. Cancer is devastating at any age but feels incredibly cruel when it strikes a young person. Infertility is associated with extreme anxiety no matter the cause (Lawson, et al., 2014) . When compounded by the rapid action necessary to protect ovarian or testicular function before cancer treatment-or if options are all together not offered-the long-term consequences to psychological health are compounded. Provider awareness of this co-morbidity of treatment-specifically infertility or sterility-needs to be better understood. Reproductive health lies in a strange netherworld between issues that affect one's life and those that are categorized under quality of life (QOL). Based on these narratives and the many other oncofertility patients I have encountered, reproductive function needs to be categorized in a new way-perhaps as an integrating life force. The terminology may be clunky but it suggests a way for healthcare providers and perhaps even insurance providers to think about fertility concerns in a new way.
Oncofertility: Promising Beginnings, a Long Way to Go
As noted above, there is no topic that is more in the crosshairs of oncofertility policy discussions than the issue of finances for oncofertility patients. The Oncofertility Consortium advocates with patient advocacy groups through (a) providing authoritative research papers that argue pros and cons of insurance or detailing the pricing that inclusion of oncofertility patients in reimbursement plans require, and (b) advocating on capitol hill along with the American Medical Association (AMA) to consider oncofertility as a mandate in the same manner that breast reconstruction and wigs for cancer patients are listed as a federal mandate on insurance plans. Infertility coverage in the US is not universal and costs of interventions are quite substantial. This is true for general infertility patients as well and there are no professional or patient-based arguments being made to cap the costs. This elephant in the embryology lab must eventually be dealt with to make biological family building affordable.
Oncofertility as a word was born in 2006. Babies are being born today to young cancer patients. Oncofertility: the word is not hyphenated. This semantically demonstrates that both oncologists and reproductive specialists must be part of the solution to this emerging urgent unmet need. More and more patients, as well as specialists, are aware that options exist and that there is a need to act quickly to provide realistic options to preserve fertility and ensure that the psychological damage associated with fertility loss is mitigated. However not everyone is included in this medial reality. Our program began working toward a series of comprehensive solutions for young cancer patients but the work has taken time and as the narratives suggest, there are miles to go before everyone is included in this new medical tent.
